PBMG Update

The PBMG Update provides information on news and features added to the Pregnancy and Breastfeeding Medicines Guide (PBMG).

July 2020

Two new medicine profiles – obinutuzumab and nivolumab have been added to the medicine library.

The venlafaxine and paroxetine patient information fact sheet has been reviewed and updated to reflect current recommendations in pregnancy and breastfeeding.

St John’s wort and aloe vera have been reviewed and uploaded to the CAM library.

One hundred and nine (109) medicine profiles have been reviewed and updated, including anti-infective, endocrine and diagnostic medicines.

 

May 2020

One new medicine profile – idelalisib has been added to the medicine library.

One hundred and twenty three (123) medicine profiles have been reviewed and updated, including genitourinary, anaesthetics, analgesics, antidotes, eye, ear, nose and throat (ENT) and allergy and anaphylaxis medicines.

The Vaccines therapeutic group has been reviewed and updated to reflect current recommendations in pregnancy and breastfeeding.

Echinacea has been reviewed and uploaded to the CAM library.

 

March 2020

Two new medicine profiles – dabrafenib and ibrutinib have been added to the medicine library.

Ninety-eight (89) medicine profiles have been reviewed and updated, including cardiovascular, vaccines and immunomodulator and antineoplastic medicines.

The amitriptyline patient fact sheet has been reviewed and uploaded to the website.

 

January 2020

Two new medicine profiles – bendamustine and cobimetinib have been added to the medicine library.

Sixty-three (63) medicine profiles have been reviewed and updated, including cardiovascular and immunomodulator and antineoplastic medicines.

 

November 2019

The venlafaxine patient fact sheet has been reviewed and uploaded to the website

Two new medicine profiles – bethanechol and afatinib have been added to the medicine library.

The Asthma Medicines therapeutic group has been reviewed and updated to reflect current recommendations in pregnancy and breastfeeding.

Ninety-eight (98) medicine profiles have been reviewed and updated, including cardiovascular, dermatological and immunomodulator and antineoplastic medicines.

Last Updated: 20 July 2020

PBMG Updates

For information about newly added and reviewed content please see our PBMG Updates.

Benefits of subscribing

Access to current and unbiased information anytime, anywhere on any internet-enabled device

Summarises key findings and provides detailed, practical recommendations on the use of medicines during pregnancy and breastfeeding to support the clinical decision making process

All available information is fully referenced; peer reviewed and is constantly updated.

Downloadable medicine fact sheets for patients

Subscription types

INDIVIDUAL users – $170 annually, inc. GST

For group or organisation subscriptions please contact us

Practical recommendations

The Therapeutic Goods Administration (TGA) pregnancy categories and manufacturer’s product information are sometimes difficult to interpret. The Women’s PBMG has developed a series of practical recommendations for medicines used during pregnancy and breastfeeding.